Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

Paying users zone. Data is hidden behind: .

  • Get 1-month access to Vertex Pharmaceuticals Inc. for $15.99, or

  • get full access to the entire website for at least 3 months from $49.99.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Income Statement

Beginner level

Vertex Pharmaceuticals Inc., consolidated income statement

US$ in thousands

Microsoft Excel LibreOffice Calc
12 months ended: Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Product revenues, net
Collaborative and royalty revenues
Cost of sales
Gross profit
Research and development expenses
Sales, general and administrative expenses
Change in fair value of contingent consideration
Restructuring income (expenses)
Intangible asset impairment charges
Income (loss) from operations
Interest income
Interest expense
Other income (expense), net
Income (loss) before (provision for) benefit from income taxes
(Provision for) benefit from income taxes
Net income (loss)
(Income) loss attributable to noncontrolling interest
Net income (loss) attributable to Vertex

Based on: 10-K (filing date: 2020-02-13), 10-K (filing date: 2019-02-13), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-16).

Income statement item Description The company
Revenues Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Vertex Pharmaceuticals Inc.’s revenues increased from 2017 to 2018 and from 2018 to 2019.
Income (loss) from operations The net result for the period of deducting operating expenses from operating revenues. Vertex Pharmaceuticals Inc.’s income (loss) from operations increased from 2017 to 2018 and from 2018 to 2019.
Income (loss) before (provision for) benefit from income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Vertex Pharmaceuticals Inc.’s income (loss) before (provision for) benefit from income taxes increased from 2017 to 2018 and from 2018 to 2019.
Net income (loss) attributable to Vertex The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Vertex Pharmaceuticals Inc.’s net income (loss) attributable to Vertex increased from 2017 to 2018 but then slightly decreased from 2018 to 2019 not reaching 2017 level.